Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0213
Host Cell : CHO-K1 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0213 |
| Description | This cell line is engineered to stably overexpress the mouse Vsir in CHO-K1 cells. |
| Introduction | This cell line is constructed by transfection of mouse V-set immunoregulatory receptor (Vsir) into CHO-K1, followed by stable cell selection. The expression of Vsir has been analyzed through flow cytometry. |
| Target Gene | Vsir |
| Gene Species | Mus musculus (Mouse) |
| Host Cell | CHO-K1 |
| Host Cell Species | Cricetulus griseus (Chinese hamster) |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
A: The Mouse Vsir Stable Cell Line - CHO-K1 typically features the introduction of multiple viral integration sites (Viral Integrating Sites or Vsir) that allow for the stable integration of multiple transgenes. These sites are engineered to facilitate the insertion of foreign genes without disrupting the host genome, which is crucial for protein production and gene therapy studies. The genetic modifications also include the use of selectable markers to ensure the cells that have integrated the desired transgenes can be isolated and expanded.
A: The Mouse Vsir Stable Cell Line - CHO-K1 is known for its robust growth and high protein production capabilities. Compared to other CHO cell lines, it may exhibit faster growth rates, higher cell density, and potentially better stability of the expressed proteins. These characteristics make it a preferred choice for large-scale biomanufacturing processes.
A: The Mouse Vsir Stable Cell Line - CHO-K1 is widely used for the production of monoclonal antibodies, recombinant proteins, and other biopharmaceuticals. Its ability to stably integrate and express multiple genes makes it an ideal platform for the development of complex therapeutics, such as bispecific antibodies and multi-subunit proteins.
A: The Mouse Vsir Stable Cell Line - CHO-K1 can adapt to various culture conditions, including serum-free media and different oxygen levels. Optimal growth conditions typically involve a nutrient-rich medium, a controlled temperature of around 37°C, and a pH range of 7.2 to 7.4. For protein production, the cells may require additional supplements, such as growth factors or specific nutrients, depending on the protein being expressed.
A: The Mouse Vsir Stable Cell Line - CHO-K1 can be engineered to produce patient-specific antibodies or other therapeutic proteins. This enables the development of personalized treatments, such as customized antibodies for cancer therapy, which can target specific tumor antigens without affecting healthy cells.
A: The Mouse Vsir Stable Cell Line - CHO-K1 can be used to produce antigens or adjuvants for vaccine development. Its high protein production capabilities allow for the efficient production of these components, which can then be formulated into vaccines for various infectious diseases.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.